Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Advancing Translational Sciences Open Data News

Advancing Translational Sciences Open Data News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Advancing Translational Sciences Open Data. Real-time updates on events, politics, business and more.

EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities

December 25, 2021
EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities - read this article along with other careers information, tips and advice on BioSpace
United Kingdom National Institute Of Health Vanderbilt University Medical Center Department Of Defense Washington University Department Of Health
Source: biospace.com

EVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19

December 9, 2021
09.12.2021 - AstraZenecas EVUSHELD (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorization (EUA) in the US for the pre-exposure prophylaxis (prevention) of COVID-19, with first doses ...
United States United Kingdom Brian Koffman Myronj Levin National Institute Of Health Vanderbilt University Medical Center
Source: wallstreet-online.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science